Invesaro

Stocks Health care DVA

NYSE · Health care

Davita Inc. (DVA)

Davita Inc. brought in $14B of revenue over the twelve months to June 30, 2026, up 6.4% from a year earlier. Net income was $847.5M, a net margin of 6.0%. Operating cash flow minus capital spending left $1.3B of free cash flow in fiscal 2025. At June 30, 2026 it held $669M in cash against $10.8B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

Price
$178.47
+2.18% on the day · September 25, 2026
52-week range $101.00 to $247.49
Market cap
$11.4B
Revenue (last 12 months)
$14B
+6.4% year on year
Net margin
6.0%
P/E
18.1
on FY2025 diluted EPS

What Davita Inc. does

Davita Inc. is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NYSE under the ticker DVA.

Revenue and profit by year

Revenue
FY18: $11.4B $11.4B FY18FY19: $11.4B $11.4B FY19FY20: $11.6B $11.6B FY20FY21: $11.6B $11.6B FY21FY22: $11.6B $11.6B FY22FY23: $12.1B $12.1B FY23FY24: $12.8B $12.8B FY24FY25: $13.6B $13.6B FY25
Net income
FY18: $159.4M $159.4M FY18FY19: $811M $811M FY19FY20: $773.6M $773.6M FY20FY21: $978.5M $978.5M FY21FY22: $560.4M $560.4M FY22FY23: $691.5M $691.5M FY23FY24: $936.3M $936.3M FY24FY25: $746.8M $746.8M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$13.6B$2B$746.8M$9.84$1.3B
2024$12.8B$2.1B$936.3M$10.73$1.5B
2023$12.1B$1.6B$691.5M$7.42$1.5B
2022$11.6B$1.3B$560.4M$5.85$961.1M
2021$11.6B$1.8B$978.5M$8.90$1.3B
2020$11.6B$1.7B$773.6M$6.31$1.3B
Next report expected around October 28, 2026.

Estimated from its filing rhythm: 52 weeks after its report of October 29, 2025. Not a date the company has announced. See the report calendar

Where DVA ranks in Health care

Revenue$13.6B
#36 of 523 in Health care · Top 7%
Revenue growth+6.5%
#285 of 437 in Health care · Bottom 35%
Net margin5.5%
#141 of 447 in Health care · Top 31%
Free cash flow margin9.6%
#119 of 408 in Health care · Top 29%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Davita Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 4, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. August 4, 2026
    Quarterly results 8-K
  3. June 17, 2026
    Employee plan annual report 11-K
  4. June 8, 2026
    Material agreement 8-K
  5. May 5, 2026
    Quarterly report 10-Q · period to March 31, 2026
  6. May 5, 2026
    Quarterly results 8-K
  7. April 22, 2026
    Annual report to shareholders ARS
  8. April 22, 2026
    Additional proxy material DEFA14A
  9. April 22, 2026
    Proxy statement DEF 14A
  10. March 26, 2026
    Passive stake changed SCHEDULE 13G/A

Recent insider filings (Forms 3, 4 and 144): 9, the latest on September 24, 2026. Insider transactions on SEC

What is DVA worth? A DCF from its reported cash flow

Insider trades

What the people running Davita Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 22, 2026 Maughan David PaulChief Operating Officer, DKC Shares withheld for tax 7,501 $182.34 $1.4M Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about DVA

What does Davita Inc. do?

Davita Inc. is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NYSE under the ticker DVA.

Is Davita Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $847.5M on revenue of $14B, a net margin of 6.0%.

How much revenue does Davita Inc. make?

Over the twelve months to June 30, 2026 Davita Inc. reported revenue of $14B. That is 6.4% more than a year earlier.

When did Davita Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 24, 2026.

Similar companies

AGL
agilon health, inc.
PGNY
Progyny, Inc.
SHC
Sotera Health Co
VMD
Viemed Healthcare, Inc.
PARK
Park Dental Partners, Inc.
PCAI
Powercheck AI Holdings Ltd

Compare DVA with

DVAvsAGL
agilon health
DVAvsPGNY
Progyny
DVAvsSHC
Sotera Health
DVAvsVMD
Viemed Healthcare

Compare DVA with any company

Follow DVA

Get an email when Davita Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow DVA: get an email when it files

Where the numbers come from

Financial figures are the values Davita Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.